ClinicalTrialsFinder

PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer

PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.400 enrolled2 locationsNCT07111832